We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > VIDO-InterVac

News List

Canada’s USask reports positive preclinical data for Covid-19 vaccine pharmaceutical-technology
May 27, 2020
The University of Saskatchewan (USask) in Canada has reported positive data from preclinical studies of the Covid-19 vaccine candidate developed by its Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).
ZYUS, VIDO-InterVac collaborate to develop plant-based vaccine for Covid-19 disease pharmaceutical-business-review
May 12, 2020
ZYUS Life Sciences has collaborated with University of Saskatchewan’s Vaccine and Infectious Disease Organisation-International Vaccine Centre (VIDO-InterVac) for the development of a plant-based vaccine for Covid-19 disease.